Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Delayed Quote USD

AbCellera Biologics Inc. (ABCL)

Compare
2.0900
0.0000
(0.00%)
At close: April 4 at 4:00:02 PM EDT
1.9300
-0.16
(-7.66%)
Pre-Market: 6:00:08 AM EDT
Advanced Chart
Loading Chart for ABCL
  • Previous Close 2.0900
  • Open 2.0200
  • Bid 2.0600 x 2500
  • Ask 2.0900 x 2400
  • Day's Range 1.9312 - 2.1000
  • 52 Week Range 1.9300 - 4.7500
  • Volume 4,832,360
  • Avg. Volume 4,142,566
  • Market Cap (intraday) 622.795M
  • Beta (5Y Monthly) 0.49
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5500
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 11.86

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

www.abcellera.com

596

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about AbCellera Biologics Inc.

Recent News: ABCL

View More
View More

Performance Overview: ABCL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ABCL
28.67%
S&P 500 (^GSPC)
13.73%

1-Year Return

ABCL
52.50%
S&P 500 (^GSPC)
1.42%

3-Year Return

ABCL
79.92%
S&P 500 (^GSPC)
10.72%

5-Year Return

ABCL
96.57%
S&P 500 (^GSPC)
103.89%

Compare To: ABCL

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

ABCL
AbCellera Biologics Inc.
2.0900
0.00%
Mkt Cap 622.795M
Industry Biotechnology
NTLA
Intellia Therapeutics, Inc.
6.63
-3.77%
Mkt Cap 686.318M
Industry Biotechnology
ABSI
Absci Corporation
2.2800
+2.01%
Mkt Cap 290.365M
Industry Biotechnology
BEAM
Beam Therapeutics Inc.
15.27
-7.23%
Mkt Cap 1.525B
Industry Biotechnology
CRBU
Caribou Biosciences, Inc.
0.7675
-2.23%
Mkt Cap 71.381M
Industry Biotechnology
EDIT
Editas Medicine, Inc.
1.0300
-8.04%
Mkt Cap 85.466M
Industry Biotechnology
RXRX
Recursion Pharmaceuticals, Inc.
4.2400
-11.85%
Mkt Cap 1.704B
Industry Biotechnology
VERV
Verve Therapeutics, Inc.
3.6200
-5.85%
Mkt Cap 321.441M
Industry Biotechnology
IOVA
Iovance Biotherapeutics, Inc.
3.0000
-7.69%
Mkt Cap 983.631M
Industry Biotechnology
SGMO
Sangamo Therapeutics, Inc.
0.6565
+5.50%
Mkt Cap 147.522M
Industry Biotechnology
FATE
Fate Therapeutics, Inc.
0.7529
+10.72%
Mkt Cap 86.28M
Industry Biotechnology

Statistics: ABCL

View More

Valuation Measures

Annual
As of 4/4/2025

  • Market Cap

    621.30M

  • Enterprise Value

    61.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    21.28

  • Price/Book (mrq)

    0.59

  • Enterprise Value/Revenue

    2.12

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -12.41%

  • Return on Equity (ttm)

    -14.75%

  • Revenue (ttm)

    28.83M

  • Net Income Avi to Common (ttm)

    -162.86M

  • Diluted EPS (ttm)

    -0.5500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    625.61M

  • Total Debt/Equity (mrq)

    6.19%

  • Levered Free Cash Flow (ttm)

    -177.77M

View More

Research Analysis: ABCL

View More
View More

Company Insights: ABCL

Research Reports: ABCL

View More
View More

People Also Watch

CERT Certara, Inc.
9.55
-2.35%
 
BEAM Beam Therapeutics Inc.
15.27
-7.23%
 
NTLA Intellia Therapeutics, Inc.
6.63
-3.77%
 
PACB Pacific Biosciences of California, Inc.
1.2300
+3.36%
 
SDGR Schrödinger, Inc.
18.03
-4.45%
 
TWST Twist Bioscience Corporation
36.19
-3.49%
 
EDIT Editas Medicine, Inc.
1.0300
-8.04%
 
CRBU Caribou Biosciences, Inc.
0.7675
-2.23%
 
MRVI Maravai LifeSciences Holdings, Inc.
1.9400
-7.62%
 
CVAC CureVac N.V.
2.5900
-8.80%
 
SEER Seer, Inc.
1.7100
+3.01%
 
ALLO Allogene Therapeutics, Inc.
1.4400
+4.35%
 
RLAY Relay Therapeutics, Inc.
2.0000
-12.66%
 
SANA Sana Biotechnology, Inc.
1.4800
+8.03%
 
VIR Vir Biotechnology, Inc.
5.58
-6.38%
 
AMWL American Well Corporation
6.59
-3.23%